These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9211022)

  • 1. ACE inhibitors in heart failure: prospects and limitations.
    Pitt B
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():285-90. PubMed ID: 9211022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
    Pitt B; Chang P; Timmermans PB
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
    Pitt B; Chang P; Grossman W; Dunlay M; Timmermans PB
    Am J Cardiol; 1996 Nov; 78(10):1129-31. PubMed ID: 8914876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.
    Brunner-La Rocca HP; Vaddadi G; Esler MD
    J Am Coll Cardiol; 1999 Apr; 33(5):1163-73. PubMed ID: 10193712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
    Doggrell SA
    Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of heart failure--an overview.
    Erdmann E
    Basic Res Cardiol; 2000; 95 Suppl 1():I3-7. PubMed ID: 11192349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists in chronic heart failure: where do they fit?
    Houghton AR
    Drugs; 2002; 62(10):1433-40. PubMed ID: 12093312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors in heart failure: an update.
    Smith WH; Ball SG
    Basic Res Cardiol; 2000; 95 Suppl 1():I8-14. PubMed ID: 11192359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
    Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitor use in elderly patients with systolic left ventricular dysfunction: problems and opportunities.
    Pitt B
    Br J Clin Pract Suppl; 1996 Jul; 84():11-6. PubMed ID: 8994996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B
    Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.